Literature DB >> 22422387

Pathological correlation with diffusion restriction on diffusion-weighted imaging in patients with pathological complete response after neoadjuvant chemoradiation therapy for locally advanced rectal cancer: preliminary results.

K M Jang1, S H Kim, D Choi, S J Lee, M J Park, K Min.   

Abstract

OBJECTIVE: The objective of this study was to assess causative pathological factors associated with diffusion restriction on diffusion-weighted imaging (DWI) in patients who achieved pathological complete response (pCR) after treatment with neoadjuvant chemoradiation therapy (CRT) for locally advanced rectal cancer.
METHODS: In total, 43 patients with locally advanced rectal cancer (≥T3 or lymph node positive) who underwent neoadjuvant CRT, subsequent surgery and ultimately achieved pCR were enrolled. All patients underwent pre- and post-CRT 3.0 T rectal MRI with DWI. Two radiologists blinded to pathological staging reviewed pre- and post-CRT 3.0 T rectal MRI for the presence of diffusion restriction in the corresponding tumour areas on post-CRT DWI, with a third radiologist arbitrating any disagreement. The consensus of these findings was then correlated with pathological data such as intramural mucin and the degree of proctitis and mural fibrosis seen on surgical specimen. Additionally, the pre-CRT tumour volume was measured to define the effect of this variable on the degree of radiation proctitis and fibrosis, as well as the presence of intramural mucin.
RESULTS: Diffusion restriction occurred in 18 subjects (41.9%), while 25 subjects remained diffusion restriction-free (58.1%). The diffusion restriction group tended to have more severe proctitis and mural fibrosis when compared with non-diffusion restriction group (p<0.001). Intramural mucin was also more common in the diffusion restriction group (p=0.052). Higher pre-CRT tumour volumes were significantly predictive of the degree of proctitis (p=0.0247) and fibrosis (p=0.0445), but not the presence of intramural mucin (p=0.0944). Proctitis and mural fibrosis severity were also identified as independent pathological risk factors for diffusion restriction on multivariate analysis (p=0.0073 and 0.0011, respectively).
CONCLUSION: Both radiation-induced proctitis and fibrosis were significant and independent predictors of diffusion restriction in patients achieving pCR after treatment with neoadjuvant CRT for locally advanced rectal cancer, and pre-CRT tumour volume significantly affects both variables.

Entities:  

Mesh:

Year:  2012        PMID: 22422387      PMCID: PMC3487069          DOI: 10.1259/bjr/24557556

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  18 in total

Review 1.  NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer.

Authors: 
Journal:  JAMA       Date:  1990-09-19       Impact factor: 56.272

Review 2.  Diffusion-weighted imaging in tissues: theoretical models.

Authors:  A Szafer; J Zhong; A W Anderson; J C Gore
Journal:  NMR Biomed       Date:  1995 Nov-Dec       Impact factor: 4.044

3.  Assessment of response to radiotherapy for prostate cancer: value of diffusion-weighted MRI at 3 T.

Authors:  Inyoung Song; Chan Kyo Kim; Byung Kwan Park; Won Park
Journal:  AJR Am J Roentgenol       Date:  2010-06       Impact factor: 3.959

4.  Randomised trial of surgery alone versus radiotherapy followed by surgery for potentially operable locally advanced rectal cancer. Medical Research Council Rectal Cancer Working Party.

Authors: 
Journal:  Lancet       Date:  1996-12-14       Impact factor: 79.321

5.  The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer.

Authors:  Fabio Maria Vecchio; Vincenzo Valentini; Bruce D Minsky; Gilbert D A Padula; Ennapadam S Venkatraman; Mario Balducci; Francesco Miccichè; Riccardo Ricci; Alessio Giuseppe Morganti; Maria Antonietta Gambacorta; Francesca Maurizi; Claudio Coco
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-07-01       Impact factor: 7.038

6.  Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients.

Authors:  Mark Bonnen; Christopher Crane; Jean-Nicolas Vauthey; John Skibber; Marc E Delclos; Miguel Rodriguez-Bigas; Paulo M Hoff; Edward Lin; Cathy Eng; Adrian Wong; Nora A Janjan; Barry W Feig
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-11-15       Impact factor: 7.038

7.  How accurate is magnetic resonance imaging in restaging rectal cancer in patients receiving preoperative combined chemoradiotherapy?

Authors:  Chien-Chih Chen; Rheun-Chuan Lee; Jen-Kou Lin; Ling-Wei Wang; Shung-Haur Yang
Journal:  Dis Colon Rectum       Date:  2005-04       Impact factor: 4.585

8.  High-grade acute organ toxicity during preoperative radiochemotherapy as positive predictor for complete histopathologic tumor regression in multimodal treatment of locally advanced rectal cancer.

Authors:  Hendrik Andreas Wolff; Jochen Gaedcke; Klaus Jung; Robert Michael Hermann; Hilka Rothe; Markus Schirmer; Torsten Liersch; Markus Karl Alfred Herrmann; Steffen Hennies; Margret Rave-Fränk; Clemens Friedrich Hess; Hans Christiansen
Journal:  Strahlenther Onkol       Date:  2009-12-28       Impact factor: 3.621

9.  Diffusion MRI for prediction of response of rectal cancer to chemoradiation.

Authors:  Andrzej Dzik-Jurasz; Claudia Domenig; Mark George; Jan Wolber; Anwar Padhani; Gina Brown; Simon Doran
Journal:  Lancet       Date:  2002-07-27       Impact factor: 79.321

10.  Patterns of morphologic alteration in residual rectal carcinoma following preoperative chemoradiation and their association with long-term outcome.

Authors:  Jinru Shia; Jose G Guillem; Harvey G Moore; Satish K Tickoo; Jing Qin; Leyo Ruo; Arief Suriawinata; Philip B Paty; Bruce D Minsky; Martin R Weiser; Larissa K Temple; W Douglas Wong; David S Klimstra
Journal:  Am J Surg Pathol       Date:  2004-02       Impact factor: 6.394

View more
  11 in total

1.  Intravoxel Incoherent Motion-derived Histogram Metrics for Assessment of Response after Combined Chemotherapy and Radiation Therapy in Rectal Cancer: Initial Experience and Comparison between Single-Section and Volumetric Analyses.

Authors:  Stephanie Nougaret; Hebert Alberto Vargas; Yulia Lakhman; Romain Sudre; Richard K G Do; Frederic Bibeau; David Azria; Eric Assenat; Nicolas Molinari; Marie-Ange Pierredon; Philippe Rouanet; Boris Guiu
Journal:  Radiology       Date:  2016-02-26       Impact factor: 11.105

Review 2.  Functional MRI for quantitative treatment response prediction in locally advanced rectal cancer.

Authors:  Trang T Pham; Gary P Liney; Karen Wong; Michael B Barton
Journal:  Br J Radiol       Date:  2017-03-07       Impact factor: 3.039

Review 3.  Advances in diffusion-weighted imaging.

Authors:  Lorenzo Mannelli; Stephanie Nougaret; Hebert A Vargas; Richard K G Do
Journal:  Radiol Clin North Am       Date:  2015-05       Impact factor: 2.303

Review 4.  Diffusion MRI in early cancer therapeutic response assessment.

Authors:  C J Galbán; B A Hoff; T L Chenevert; B D Ross
Journal:  NMR Biomed       Date:  2016-01-15       Impact factor: 4.044

Review 5.  Therapy response with diffusion MRI: an update.

Authors:  Lauren J Bains; Martin Zweifel; Harriet C Thoeny
Journal:  Cancer Imaging       Date:  2012-09-28       Impact factor: 3.909

6.  The role of perfusion effects in monitoring of chemoradiotherapy of rectal carcinoma using diffusion-weighted imaging.

Authors:  Maria-Katharina Ganten; Maximilian Schuessler; Tobias Bäuerle; Marc Muenter; Heinz-Peter Schlemmer; Alexandra Jensen; Karsten Brand; Margret Dueck; Julien Dinkel; Annette Kopp-Schneider; Klaus Fritzsche; Bram Stieltjes
Journal:  Cancer Imaging       Date:  2013-12-11       Impact factor: 3.909

Review 7.  Role of quantitative magnetic resonance imaging parameters in the evaluation of treatment response in malignant tumors.

Authors:  Qing-Gang Xu; Jun-Fang Xian
Journal:  Chin Med J (Engl)       Date:  2015-04-20       Impact factor: 2.628

8.  Quantitative Aspects of Diffusion-weighted Magnetic Resonance Imaging in Rectal Cancer Response to Neoadjuvant Therapy.

Authors:  Thiago Bassaneze; José Eduardo Gonçalves; Juliano Ferreira Faria; Rogério Tadeu Palma; Jaques Waisberg
Journal:  Radiol Oncol       Date:  2017-06-25       Impact factor: 2.991

9.  Correlation of ultra-high field MRI with histopathology for evaluation of rectal cancer heterogeneity.

Authors:  Trang T Pham; Timothy Stait-Gardner; Cheok Soon Lee; Michael Barton; Petra L Graham; Gary Liney; Karen Wong; William S Price
Journal:  Sci Rep       Date:  2019-06-27       Impact factor: 4.379

10.  Mean Corpuscular Volume as a Predictive Factor of Response to Preoperative Chemoradiotherapy in Locally Advanced Rectal Cancer.

Authors:  Wen-Yi Zhang; Xing-Xing Chen; Wen-Hao Chen; Hui Zhang; Chang-Lin Zou
Journal:  Gastroenterol Res Pract       Date:  2018-03-18       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.